Advertisement

Les différents types histologiques des cancers ovariens

  • I. Treilleux
Part of the Abord clinique book series (ONCOLPRAT)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Chen V, Ruiz B, Kileen J et al. (2003) Pathology and classification of ovarian tumors. Cancer 97: 2631–42PubMedGoogle Scholar
  2. 2.
    Scully R, Young R, Clement P (1998) Ovarians tumors. In: Armed Forces Institute of Pathology (ed) Tumors of the ovary, maldevelopped gonads, fallopian tube and broad ligament. Bethesda, p 1–456Google Scholar
  3. 3.
    Tavassoli T, Devilee P Tumours of the ovary and peritoneum. In: International Agency for Research Cancer (ed) Pathology and genetics of tumours of the breast and female genital organs. Lyon, p 114–202Google Scholar
  4. 4.
    Seidman J, Horkayne-Szakaly I, Haiba M et al. (2004) The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 23: 41–4PubMedGoogle Scholar
  5. 5.
    Seidman J, Soslow R, Vang R et al. (2004) Borderline ovarian tumors: diverse contemporary view-points on terminology and diagnostic criteria with illustrative images. Hum Pathol 35: 918–33CrossRefPubMedGoogle Scholar
  6. 6.
    Silverberg S, Bell D, Kurman R et al. (2004) Borderline ovarian tumors: key point and workshop summary. Hum Pathol 35: 910–7CrossRefPubMedGoogle Scholar
  7. 7.
    Prat J (1999) Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal. Adv Anat Pathol 6: 247–74PubMedGoogle Scholar
  8. 8.
    Shih I, Kurman R (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164: 1511–8PubMedGoogle Scholar
  9. 9.
    Singer G, Stöhr R, Cope L et al. (2005) Patterns of p53 mutations separate ovarian serous borderline tumors and low-and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis. Am J Surg Pathol 29: 218–24PubMedGoogle Scholar
  10. 10.
    Dinulescu D, Ince T, Quade B et al. (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11: 63–70CrossRefPubMedGoogle Scholar
  11. 11.
    Bell D, Longacre T, Prat J et al. (2004) Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 35: 934–948CrossRefPubMedGoogle Scholar
  12. 12.
    Prat J, De Nictolis M (2002) Serous borderline tumors of the ovary. A long-term follow-up study of 137 cases, including 18 with micropapillary pattern and 20 with micro-invasion. Am J Surg Pathol 26: 1111–28CrossRefPubMedGoogle Scholar
  13. 13.
    Hart W (2004) Mucinous tumors of the ovary: a review. Int J Gynecol Pathol 24: 4–25Google Scholar
  14. 14.
    Lee K, Scully R (2000) Mucinous tumors of the ovary. A clinicopathologic study of 196 borderline tumors of intestinal type and carcinomas, including an evaluation of 11 cases with pseudomyxoma peritonei. Am J Surg Pathol 24: 1447–64CrossRefPubMedGoogle Scholar
  15. 15.
    Lee K, Young R (2003) The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic finding in 50 cases. Am J Surg Pathol 27: 281–92CrossRefPubMedGoogle Scholar
  16. 16.
    Seidman J, Jurman R, Ronnett B (2003) Primary and metastatic mucinous adenocarcinomas in the ovaries. Incidence in routine pratice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 27: 985–93CrossRefPubMedGoogle Scholar
  17. 17.
    Riopel M, Ronnett B, Kurman R (1999) Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intra-epithelial, microinvasive, invasive and metastatic carcinomas. Am J Surg Pathol 23: 617–35CrossRefPubMedGoogle Scholar
  18. 18.
    Ronnett B, Kajdacsy-Balla A, Gilks C et al. (2004) Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria and behavior. Hum Pathol 35: 949–60CrossRefPubMedGoogle Scholar
  19. 19.
    Baker P, Oliva E (2004) Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol 24: 39–55Google Scholar
  20. 20.
    Bell K, Kurman R (2000) A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol 24: 1465–79PubMedGoogle Scholar
  21. 21.
    Silverberg S (2000) Histologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 19: 7–15PubMedGoogle Scholar
  22. 22.
    Gilks C (2004) Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol 23: 200–5PubMedGoogle Scholar
  23. 23.
    Riener E, Arnold N, Kommos F et al. (2004) The prognostic and predictive value of immunohistochemically detected HER2/Neu overexpression in 361 patients with ovarian cancer: a multicenter study. Gynecol Oncol 95: 89–94CrossRefPubMedGoogle Scholar
  24. 24.
    Camilleri-Broet S, Hardy-Bessard A, Le Tourneau A et al. (2004) HER2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group. Ann Oncol 15: 104–12CrossRefPubMedGoogle Scholar
  25. 25.
    Skirnisdottir I, Seidal T, Sorbe B (2004) A new prognostic model comprising p53, EGFR and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inac-curate surgical staging. Int J Gynecol Pathol 14: 259–70Google Scholar
  26. 26.
    Elie C, Geay J, Morcos M et al. (2004) Lack of relationchip between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group). Br J Cancer 91: 470–5CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2006

Authors and Affiliations

  • I. Treilleux

There are no affiliations available

Personalised recommendations